NCT01669005
- Conditions
- Agranulocytosis, Cytopenia, Hematologic Diseases, +5 more
- Locations
-
Not specified
Clinical trial condition
Leukocyte Disorders
Explore clinical trials studying Leukocyte Disorders. Study availability and eligibility vary by location and protocol.
737 public trials
106 recruiting studies
Leukocyte Disorders trial results
Completed
2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)
NCT00483067
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- U.T.M.D. Anderson Cancer Center Houston, Texas, United States
NCT00684008
- Conditions
- AML, CML, Cytopenia, +10 more
- Locations
-
- Memorial Sloan-Kettering Cancer Institute New York, United States
Completed
Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia
NCT00913042
- Conditions
- Agranulocytosis, Bacteremia, Bacterial Infections, +19 more
- Locations
-
- Hematology Department, Paris 12 University Hospital Henri Mondor Créteil, France
NCT00608738
- Conditions
- Agranulocytosis, Blood Platelet Disorders, Chemotherapeutic Agent Toxicity, +17 more
- Locations
-
Not specified
NCT00002719
- Conditions
- Agranulocytosis, Bone Marrow Diseases, Cytopenia, +15 more
- Locations
-
- Azienda Policlinico Umberto Primo Rome, Italy
Completed
AMD 3100 for Treatment of Myelokathexis
NCT01058993
- Conditions
- Agranulocytosis, Cytopenia, Hematologic Diseases, +5 more
- Locations
-
- University of Washington Medical Center Seattle, Washington, United States
NCT00275561
- Conditions
- Deglutition Disorders, Digestive System Diseases, Eosinophilia, +13 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00132015
- Conditions
- Angiolymphoid Hyperplasia with Eosinophilia, Blood Coagulation Disorders, Blood Platelet Disorders, +61 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
- NCI - Center for Cancer Research Bethesda, Maryland, United States
Completed
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
NCT01040598
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
- Locations
-
- O & O Alpan LLC Springfield, Virginia, United States